An official website of the United States government
10/04/2021: Lab Alert: Ellume Issues Voluntary Recall of Specific Lots of Ellume COVID-19 Home Tests
Audience: Clinical Laboratory Professionals
Level: Laboratory Alert
On October 1, 2021, the digital diagnostics company Ellume announced a voluntary recall on specific lots of the Ellume COVID-19 Home Test, the company’s rapid, self-administered COVID-19 antigen test, because there is an increased chance that tests from the affected lot numbers may give a false positive result.
Ellume advises consumers to visit their website to check whether their product is part of the affected lots and, if affected, to receive further instructions.
The voluntary recall is being taken after specific product lots reported false positive test result rates higher than was observed in clinical testing. Ellume has investigated the issue, identified the root cause, implemented additional controls, and is working on resolving the issue that led to this recall. Information relating to the action to be taken by distributors and retailers for the affected lots is also provided on the company’s website.
Please share this message with your networks and invite them to opt in to LOCS to receive future updates.
Online resources:
- Information for Laboratories about Coronavirus (COVID-19)
- Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories
- CDC Coronavirus (COVID-19) Website
- CDC Laboratory Outreach Communication System (LOCS)
- Clinical Laboratory COVID-19 Response Calls
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)